Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells

Blood

Volumn 86, Issue 10, 1995, Pages 3705-3714

  Yanagida, Makoto ^a   Fukamachi, Hiromi ^b   Ohgami, Kinya ^b   Kuwaki, Tomoaki ^b   Ishii, Hiromi ^b   Uzumaki, Hiroya ^b   Amano, Kenji ^b   Tokiwa, Tomonobu ^b   Mitsui, Hideki ^b   Saito, Hirohisa ^b   Iikura, Yoji ^b   Ishizaka, Teruko ^b   Nakahata, Tatsutoshi ^b  

^a KIRIN BREWERY CO LTD   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; STEM CELL FACTOR;

ALLERGIC REACTION; APOPTOSIS; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; ETIOLOGY; HELPER CELL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; UMBILICAL CORD BLOOD;

EID: 0028785274     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.10.3705.bloodjournal86103705     Document Type: Article

References (44)

1. Ishizaka T, Ishizaka K: Activation of mast cells for mediator release through IgE receptors. Prog Allergy 34:188, 1984
2. Plaut M, Pierce JH, Watson CJ, Hanley Ohyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of FcRI or to calcium ionophores. Nature 339:64, 1989
3. Wodnar-Filipowicz A, Heusser CH, Moroni C: Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339:150, 1989
4. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245, 1989
5. + bone marrow progenitor cells. J Immunol 146:1410, 1991
6. Mitsui H, Furitsu T, Dvorak AM, Irani A-MA, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S, Ishizaka T: Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90:735, 1993
7. Valent P, Spanblöchl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237, 1992
8. + pluripotent progenitor cells. J Immunol 148:772, 1992
9. Irani AA, Nilsson G, Miettinen U, Craig SC, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB: Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009, 1992
10. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cupples RL, Zsebo KM: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203, 1990
11. Rennick DM, Lee FD, Yokota T, Arai K, Cantor H, Nabel GJ: A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: Multiple activities of interleukin 3. J Immunol 134:910, 1985
12. Rennick DM, Young G, Muller-Sieburg C, Smith C, Arai N, Tanabe Y, Gemmell L: Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc Natl Acad Sci USA 84:6889, 1987
13. Hültner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rüde E, Dörmer P, Van Snick J: Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGF III (interleukin 9). Eur J Immunol 20:1413, 1990
14. Thompson-Snipes LA, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM: Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507, 1991
15. Furitsu T, Saito H, Dvorak AM, Schwartz LB, Irani A-MA, Burdick JF, Ishizaka K, Ishizaka T: Development of human mast cells in vitro. Proc Natl Acad Sci USA 86:10039, 1989
16. Nakahata T, Tsuji K, Tanaka R, Muraoka K, Okumura N, Sawai N, Takagi M, Itoh S, Ra C, Saito H: Synergy of stem cell factor and other cytokines in mast cell development, in Kitamura Y, Yamamoto S, Galli SJ, Greaves MW (eds): Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York, NY, Raven, 1995, p 13
17. Saito H, Ebisawa M, Sakaguchi N, Onda T, Iikura Y, Yanagida M, Uzumaki H, Nakahata T: Characterization of cord-blood-derived human mast cells cultured in the presence of Steel factor and interleukin-6. Int Arch Allergy Immunol 107:63, 1995
18. Irani AA, Schecter NM, Craig SS, DeBlois G, Schwartz LB: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83:4464, 1986
19. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509, 1989
20. Dvorak AM: Monograph-procedural guide to specimen handling for the ultrastructural pathology service laboratory. J Electron Microsc Tech 6:255, 1987
21. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
22. Siraganian RP: An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 57:383, 1974
23. Sundström C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17:565, 1976
24. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
25. Kuwaki T, Kitamura T, Tojo A, Matsuki S, Tamai Y, Miyazono K, Takaku F: Characterization of human interleukin-3 receptors on a multi-factor-dependent cell line. Biochem Biophys Res Commun 161:16, 1989
26. Calvo JC, Radicella JP, Chareau EH: Measurement of specific radioactivities in labeled hormones by self displacement analysis. Biochem J 212:259, 1983
27. Valent P, Besemer J, Sillaber C, Butterfield JH, Eher R, Majdic O, Kishi K, Klepetko W, Eckersberger F, Lechner K, Bettelheim P: Failure to detect IL-3-binding sites on human mast cells. J Immunol 145:3432, 1990
28. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345, 1988
29. Bischoff SC, Dahinden CA: c-kit ligand: A unique potentiator of mediator release by human lung mast cells. J Exp Med 175:237, 1992
30. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149:599, 1992
31. Mayrhofer G, Gadd SJ, Spargo LD, Ashman LK: Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 65:241, 1987
32. Sillaber C, Strobl H, Bevec D, Ashman LK, Butterfield JH, Lechner K, Mayrer D, Bettelheim P, Valent P: IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 147:4224, 1991
33. Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani A-MA, Schwartz LB: Interleukin-4 inhibits the expression of kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84:1519, 1994
34. Shiohara M, Koike K, Kubo T, Amano Y, Takagi M, Muraoka K, Nakao J, Nakahata T, Komiyama A: Possible role of stem cell factor as a serum factor: Monoclonal anti-c-kit antibody abrogates interleukin-6-dependent colony growth in serum-containing culture. Exp Hematol 21:907, 1993
35. Mekori YA, Oh CK, Metcalfe DD: IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: Prevention of apoptosis by c-kit ligand. J Immunol 151:3775, 1993
36. Yee NS, Paek I, Besmer P: Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: Basis for radiosensitivity of white spotting and Steel mutant mice. J Exp Med 179:1777, 1994
37. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ: The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321, 1994
38. Tsuji K, Nakahata T, Takagi M, Kobayashi T, Ishiguro A, Kikuchi T, Naganuma K, Koike K, Miyajima A, Arai K, Akabane T: Effects of interleukin-3 and interleukin-4 on the development of "connective tissue-type" mast cells: Interleukin-3 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3. Blood 75:421, 1990
39. Horigome K, Bullock ED, Johnson EM Jr: Effects of nerve growth factor on rat peritoneal mast cells. J Biol Chem 269:2695, 1994
40. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348, 1986
41. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145, 1989
42. Larsen A, Davis T, Curtis BM, Gimpel S, Sims JE, Cosman D, Park L, Sorensen E, March CJ, Smith CA: Expression cloning of a human granulocyte colony-stimulating factor receptor: A structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med 172:1559, 1990
43. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A: Structural alternation of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 320:277, 1986
44. + cord blood cells stimulated with stem cell factor and interleukin-3. Blood 84:3667, 1994